Vision Point Advisory Group, LLC Novo Nordisk A S Transaction History

Vision Point Advisory Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$122.71 - $146.91 $1,840 - $2,203	-15 Reduced 2.6%	562 $80,000
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $5,105 - $6,795	-50 Reduced 7.97%	577 $74,000
Q4 2023 Feb 07, 2024	BUY	$87.78 - $105.45 $4,564 - $5,483	52 Added 9.04%	627 $64,000
Q3 2023 Dec 06, 2023	BUY	$90.94 - $199.54 $39,922 - $87,598	439 Added 322.79%	575 $52,000
Q2 2023 Aug 21, 2023	BUY	$155.98 - $172.65 $21,213 - $23,480	136 New	136 $22,000
Q4 2020 Feb 08, 2021	SELL	$63.89 - $73.8 $264,312 - $305,310	-4,137 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $55,792 - $61,512	-876 Reduced 17.47%	4,137 $287,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $3,570 - $4,144	61 Added 1.23%	5,013 $332,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $244,925 - $320,790	4,952 New	4,952 $298,000

1,868

323M

5.57M

7.6M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $189B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Vision Point Advisory Group, LLC with notifications on news.